nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Fluorouracil—colon cancer	0.317	0.471	CbGbCtD
Ganciclovir—SLC22A7—Methotrexate—colon cancer	0.175	0.26	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—colon cancer	0.107	0.159	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—colon cancer	0.0743	0.11	CbGbCtD
Ganciclovir—Confusional state—Irinotecan—colon cancer	0.000373	0.00114	CcSEcCtD
Ganciclovir—Thrombocytopenia—Vincristine—colon cancer	0.000372	0.00114	CcSEcCtD
Ganciclovir—Haematuria—Capecitabine—colon cancer	0.00037	0.00113	CcSEcCtD
Ganciclovir—Anaphylactic shock—Irinotecan—colon cancer	0.00037	0.00113	CcSEcCtD
Ganciclovir—Oedema—Irinotecan—colon cancer	0.00037	0.00113	CcSEcCtD
Ganciclovir—Chest pain—Fluorouracil—colon cancer	0.000369	0.00113	CcSEcCtD
Ganciclovir—Myalgia—Fluorouracil—colon cancer	0.000369	0.00113	CcSEcCtD
Ganciclovir—Infection—Irinotecan—colon cancer	0.000367	0.00112	CcSEcCtD
Ganciclovir—Hyperhidrosis—Vincristine—colon cancer	0.000367	0.00112	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Capecitabine—colon cancer	0.000367	0.00112	CcSEcCtD
Ganciclovir—Discomfort—Fluorouracil—colon cancer	0.000365	0.00111	CcSEcCtD
Ganciclovir—Agranulocytosis—Capecitabine—colon cancer	0.000362	0.00111	CcSEcCtD
Ganciclovir—Thrombocytopenia—Irinotecan—colon cancer	0.000362	0.00111	CcSEcCtD
Ganciclovir—Anorexia—Vincristine—colon cancer	0.000362	0.00111	CcSEcCtD
Ganciclovir—Irritability—Methotrexate—colon cancer	0.000358	0.00109	CcSEcCtD
Ganciclovir—Hyperhidrosis—Irinotecan—colon cancer	0.000357	0.00109	CcSEcCtD
Ganciclovir—Confusional state—Fluorouracil—colon cancer	0.000357	0.00109	CcSEcCtD
Ganciclovir—Mood swings—Methotrexate—colon cancer	0.000355	0.00108	CcSEcCtD
Ganciclovir—Hypotension—Vincristine—colon cancer	0.000355	0.00108	CcSEcCtD
Ganciclovir—Oedema—Fluorouracil—colon cancer	0.000354	0.00108	CcSEcCtD
Ganciclovir—Anaphylactic shock—Fluorouracil—colon cancer	0.000354	0.00108	CcSEcCtD
Ganciclovir—Anorexia—Irinotecan—colon cancer	0.000352	0.00108	CcSEcCtD
Ganciclovir—Ataxia—Methotrexate—colon cancer	0.000352	0.00108	CcSEcCtD
Ganciclovir—Infection—Fluorouracil—colon cancer	0.000352	0.00107	CcSEcCtD
Ganciclovir—Haemoglobin—Capecitabine—colon cancer	0.00035	0.00107	CcSEcCtD
Ganciclovir—Rhinitis—Capecitabine—colon cancer	0.000349	0.00107	CcSEcCtD
Ganciclovir—Hepatitis—Capecitabine—colon cancer	0.000348	0.00106	CcSEcCtD
Ganciclovir—Haemorrhage—Capecitabine—colon cancer	0.000348	0.00106	CcSEcCtD
Ganciclovir—Thrombocytopenia—Fluorouracil—colon cancer	0.000347	0.00106	CcSEcCtD
Ganciclovir—Hypoaesthesia—Capecitabine—colon cancer	0.000347	0.00106	CcSEcCtD
Ganciclovir—Liver function test abnormal—Methotrexate—colon cancer	0.000346	0.00106	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Vincristine—colon cancer	0.000346	0.00106	CcSEcCtD
Ganciclovir—Pharyngitis—Capecitabine—colon cancer	0.000346	0.00106	CcSEcCtD
Ganciclovir—Tachycardia—Fluorouracil—colon cancer	0.000346	0.00106	CcSEcCtD
Ganciclovir—Hypotension—Irinotecan—colon cancer	0.000345	0.00106	CcSEcCtD
Ganciclovir—Urinary tract disorder—Capecitabine—colon cancer	0.000344	0.00105	CcSEcCtD
Ganciclovir—Insomnia—Vincristine—colon cancer	0.000343	0.00105	CcSEcCtD
Ganciclovir—Oedema peripheral—Capecitabine—colon cancer	0.000343	0.00105	CcSEcCtD
Ganciclovir—Connective tissue disorder—Capecitabine—colon cancer	0.000342	0.00105	CcSEcCtD
Ganciclovir—Urethral disorder—Capecitabine—colon cancer	0.000341	0.00104	CcSEcCtD
Ganciclovir—Paraesthesia—Vincristine—colon cancer	0.000341	0.00104	CcSEcCtD
Ganciclovir—Anorexia—Fluorouracil—colon cancer	0.000337	0.00103	CcSEcCtD
Ganciclovir—Visual impairment—Capecitabine—colon cancer	0.000336	0.00103	CcSEcCtD
Ganciclovir—Insomnia—Irinotecan—colon cancer	0.000334	0.00102	CcSEcCtD
Ganciclovir—Paraesthesia—Irinotecan—colon cancer	0.000332	0.00101	CcSEcCtD
Ganciclovir—Hypotension—Fluorouracil—colon cancer	0.000331	0.00101	CcSEcCtD
Ganciclovir—Decreased appetite—Vincristine—colon cancer	0.00033	0.00101	CcSEcCtD
Ganciclovir—Dyspnoea—Irinotecan—colon cancer	0.00033	0.00101	CcSEcCtD
Ganciclovir—Erythema multiforme—Capecitabine—colon cancer	0.000329	0.00101	CcSEcCtD
Ganciclovir—Somnolence—Irinotecan—colon cancer	0.000329	0.001	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Vincristine—colon cancer	0.000328	0.001	CcSEcCtD
Ganciclovir—Fatigue—Vincristine—colon cancer	0.000327	0.001	CcSEcCtD
Ganciclovir—Dyspepsia—Irinotecan—colon cancer	0.000325	0.000994	CcSEcCtD
Ganciclovir—Tinnitus—Capecitabine—colon cancer	0.000325	0.000992	CcSEcCtD
Ganciclovir—Constipation—Vincristine—colon cancer	0.000325	0.000991	CcSEcCtD
Ganciclovir—Pain—Vincristine—colon cancer	0.000325	0.000991	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000323	0.000985	CcSEcCtD
Ganciclovir—Decreased appetite—Irinotecan—colon cancer	0.000321	0.000982	CcSEcCtD
Ganciclovir—Eosinophilia—Methotrexate—colon cancer	0.000321	0.000979	CcSEcCtD
Ganciclovir—Insomnia—Fluorouracil—colon cancer	0.00032	0.000978	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000319	0.000975	CcSEcCtD
Ganciclovir—Fatigue—Irinotecan—colon cancer	0.000319	0.000973	CcSEcCtD
Ganciclovir—Paraesthesia—Fluorouracil—colon cancer	0.000318	0.000971	CcSEcCtD
Ganciclovir—Pancreatitis—Methotrexate—colon cancer	0.000318	0.00097	CcSEcCtD
Ganciclovir—Pain—Irinotecan—colon cancer	0.000316	0.000966	CcSEcCtD
Ganciclovir—Constipation—Irinotecan—colon cancer	0.000316	0.000966	CcSEcCtD
Ganciclovir—Angiopathy—Capecitabine—colon cancer	0.000316	0.000965	CcSEcCtD
Ganciclovir—Dyspnoea—Fluorouracil—colon cancer	0.000316	0.000964	CcSEcCtD
Ganciclovir—Somnolence—Fluorouracil—colon cancer	0.000315	0.000961	CcSEcCtD
Ganciclovir—Mediastinal disorder—Capecitabine—colon cancer	0.000314	0.000959	CcSEcCtD
Ganciclovir—Chills—Capecitabine—colon cancer	0.000312	0.000954	CcSEcCtD
Ganciclovir—Dyspepsia—Fluorouracil—colon cancer	0.000312	0.000952	CcSEcCtD
Ganciclovir—Arrhythmia—Capecitabine—colon cancer	0.000311	0.00095	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Vincristine—colon cancer	0.00031	0.000948	CcSEcCtD
Ganciclovir—Decreased appetite—Fluorouracil—colon cancer	0.000308	0.00094	CcSEcCtD
Ganciclovir—Alopecia—Capecitabine—colon cancer	0.000308	0.00094	CcSEcCtD
Ganciclovir—Pancytopenia—Methotrexate—colon cancer	0.000308	0.000939	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000306	0.000934	CcSEcCtD
Ganciclovir—Mental disorder—Capecitabine—colon cancer	0.000305	0.000932	CcSEcCtD
Ganciclovir—Feeling abnormal—Irinotecan—colon cancer	0.000305	0.00093	CcSEcCtD
Ganciclovir—Malnutrition—Capecitabine—colon cancer	0.000303	0.000926	CcSEcCtD
Ganciclovir—Dysuria—Methotrexate—colon cancer	0.000303	0.000925	CcSEcCtD
Ganciclovir—Neutropenia—Methotrexate—colon cancer	0.000303	0.000925	CcSEcCtD
Ganciclovir—Pain—Fluorouracil—colon cancer	0.000303	0.000925	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Irinotecan—colon cancer	0.000302	0.000923	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Methotrexate—colon cancer	0.000301	0.000919	CcSEcCtD
Ganciclovir—Abdominal pain—Vincristine—colon cancer	0.0003	0.000917	CcSEcCtD
Ganciclovir—Body temperature increased—Vincristine—colon cancer	0.0003	0.000917	CcSEcCtD
Ganciclovir—Flatulence—Capecitabine—colon cancer	0.000299	0.000912	CcSEcCtD
Ganciclovir—Erectile dysfunction—Methotrexate—colon cancer	0.000298	0.000911	CcSEcCtD
Ganciclovir—Dysgeusia—Capecitabine—colon cancer	0.000297	0.000907	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Methotrexate—colon cancer	0.000296	0.000903	CcSEcCtD
Ganciclovir—Back pain—Capecitabine—colon cancer	0.000293	0.000896	CcSEcCtD
Ganciclovir—Body temperature increased—Irinotecan—colon cancer	0.000292	0.000893	CcSEcCtD
Ganciclovir—Abdominal pain—Irinotecan—colon cancer	0.000292	0.000893	CcSEcCtD
Ganciclovir—Feeling abnormal—Fluorouracil—colon cancer	0.000292	0.000891	CcSEcCtD
Ganciclovir—Muscle spasms—Capecitabine—colon cancer	0.000291	0.00089	CcSEcCtD
Ganciclovir—Pneumonia—Methotrexate—colon cancer	0.00029	0.000887	CcSEcCtD
Ganciclovir—Infestation NOS—Methotrexate—colon cancer	0.000289	0.000882	CcSEcCtD
Ganciclovir—Infestation—Methotrexate—colon cancer	0.000289	0.000882	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000286	0.000874	CcSEcCtD
Ganciclovir—Vision blurred—Capecitabine—colon cancer	0.000286	0.000873	CcSEcCtD
Ganciclovir—Tremor—Capecitabine—colon cancer	0.000284	0.000868	CcSEcCtD
Ganciclovir—Renal failure—Methotrexate—colon cancer	0.000284	0.000867	CcSEcCtD
Ganciclovir—Stomatitis—Methotrexate—colon cancer	0.000281	0.00086	CcSEcCtD
Ganciclovir—Ill-defined disorder—Capecitabine—colon cancer	0.000281	0.000859	CcSEcCtD
Ganciclovir—Urticaria—Fluorouracil—colon cancer	0.000281	0.000859	CcSEcCtD
Ganciclovir—Conjunctivitis—Methotrexate—colon cancer	0.000281	0.000857	CcSEcCtD
Ganciclovir—Anaemia—Capecitabine—colon cancer	0.00028	0.000856	CcSEcCtD
Ganciclovir—Body temperature increased—Fluorouracil—colon cancer	0.00028	0.000855	CcSEcCtD
Ganciclovir—Hypersensitivity—Vincristine—colon cancer	0.00028	0.000854	CcSEcCtD
Ganciclovir—Sweating—Methotrexate—colon cancer	0.000277	0.000846	CcSEcCtD
Ganciclovir—Haematuria—Methotrexate—colon cancer	0.000275	0.000841	CcSEcCtD
Ganciclovir—Malaise—Capecitabine—colon cancer	0.000273	0.000835	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Methotrexate—colon cancer	0.000273	0.000834	CcSEcCtD
Ganciclovir—Vertigo—Capecitabine—colon cancer	0.000272	0.000832	CcSEcCtD
Ganciclovir—Hypersensitivity—Irinotecan—colon cancer	0.000272	0.000832	CcSEcCtD
Ganciclovir—Asthenia—Vincristine—colon cancer	0.000272	0.000832	CcSEcCtD
Ganciclovir—Leukopenia—Capecitabine—colon cancer	0.000271	0.000829	CcSEcCtD
Ganciclovir—Agranulocytosis—Methotrexate—colon cancer	0.00027	0.000823	CcSEcCtD
Ganciclovir—Asthenia—Irinotecan—colon cancer	0.000265	0.00081	CcSEcCtD
Ganciclovir—Cough—Capecitabine—colon cancer	0.000265	0.000808	CcSEcCtD
Ganciclovir—Hypertension—Capecitabine—colon cancer	0.000262	0.000799	CcSEcCtD
Ganciclovir—Hypersensitivity—Fluorouracil—colon cancer	0.000261	0.000797	CcSEcCtD
Ganciclovir—Haemoglobin—Methotrexate—colon cancer	0.000261	0.000796	CcSEcCtD
Ganciclovir—Diarrhoea—Vincristine—colon cancer	0.00026	0.000793	CcSEcCtD
Ganciclovir—Haemorrhage—Methotrexate—colon cancer	0.000259	0.000792	CcSEcCtD
Ganciclovir—Hepatitis—Methotrexate—colon cancer	0.000259	0.000792	CcSEcCtD
Ganciclovir—Arthralgia—Capecitabine—colon cancer	0.000258	0.000788	CcSEcCtD
Ganciclovir—Chest pain—Capecitabine—colon cancer	0.000258	0.000788	CcSEcCtD
Ganciclovir—Myalgia—Capecitabine—colon cancer	0.000258	0.000788	CcSEcCtD
Ganciclovir—Pharyngitis—Methotrexate—colon cancer	0.000257	0.000786	CcSEcCtD
Ganciclovir—Anxiety—Capecitabine—colon cancer	0.000257	0.000786	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000256	0.000783	CcSEcCtD
Ganciclovir—Urinary tract disorder—Methotrexate—colon cancer	0.000256	0.000782	CcSEcCtD
Ganciclovir—Discomfort—Capecitabine—colon cancer	0.000255	0.000779	CcSEcCtD
Ganciclovir—Urethral disorder—Methotrexate—colon cancer	0.000254	0.000776	CcSEcCtD
Ganciclovir—Diarrhoea—Irinotecan—colon cancer	0.000253	0.000773	CcSEcCtD
Ganciclovir—Dry mouth—Capecitabine—colon cancer	0.000252	0.000771	CcSEcCtD
Ganciclovir—Dizziness—Vincristine—colon cancer	0.000251	0.000767	CcSEcCtD
Ganciclovir—Pruritus—Fluorouracil—colon cancer	0.00025	0.000765	CcSEcCtD
Ganciclovir—Visual impairment—Methotrexate—colon cancer	0.00025	0.000763	CcSEcCtD
Ganciclovir—Confusional state—Capecitabine—colon cancer	0.000249	0.000762	CcSEcCtD
Ganciclovir—Oedema—Capecitabine—colon cancer	0.000247	0.000756	CcSEcCtD
Ganciclovir—Infection—Capecitabine—colon cancer	0.000246	0.000751	CcSEcCtD
Ganciclovir—Erythema multiforme—Methotrexate—colon cancer	0.000245	0.000749	CcSEcCtD
Ganciclovir—Dizziness—Irinotecan—colon cancer	0.000244	0.000747	CcSEcCtD
Ganciclovir—Diarrhoea—Fluorouracil—colon cancer	0.000242	0.00074	CcSEcCtD
Ganciclovir—Thrombocytopenia—Capecitabine—colon cancer	0.000242	0.00074	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—colon cancer	0.000242	0.000738	CcSEcCtD
Ganciclovir—Tachycardia—Capecitabine—colon cancer	0.000241	0.000738	CcSEcCtD
Ganciclovir—Vomiting—Vincristine—colon cancer	0.000241	0.000737	CcSEcCtD
Ganciclovir—Skin disorder—Capecitabine—colon cancer	0.00024	0.000734	CcSEcCtD
Ganciclovir—Rash—Vincristine—colon cancer	0.000239	0.000731	CcSEcCtD
Ganciclovir—Hyperhidrosis—Capecitabine—colon cancer	0.000239	0.000731	CcSEcCtD
Ganciclovir—Dermatitis—Vincristine—colon cancer	0.000239	0.00073	CcSEcCtD
Ganciclovir—Headache—Vincristine—colon cancer	0.000238	0.000726	CcSEcCtD
Ganciclovir—Anorexia—Capecitabine—colon cancer	0.000236	0.00072	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—colon cancer	0.000235	0.000718	CcSEcCtD
Ganciclovir—Vomiting—Irinotecan—colon cancer	0.000235	0.000718	CcSEcCtD
Ganciclovir—Dizziness—Fluorouracil—colon cancer	0.000234	0.000715	CcSEcCtD
Ganciclovir—Mediastinal disorder—Methotrexate—colon cancer	0.000234	0.000714	CcSEcCtD
Ganciclovir—Rash—Irinotecan—colon cancer	0.000233	0.000712	CcSEcCtD
Ganciclovir—Dermatitis—Irinotecan—colon cancer	0.000233	0.000711	CcSEcCtD
Ganciclovir—Chills—Methotrexate—colon cancer	0.000233	0.00071	CcSEcCtD
Ganciclovir—Headache—Irinotecan—colon cancer	0.000232	0.000707	CcSEcCtD
Ganciclovir—Hypotension—Capecitabine—colon cancer	0.000231	0.000706	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—colon cancer	0.000229	0.0007	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—colon cancer	0.000227	0.000694	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—colon cancer	0.000226	0.000689	CcSEcCtD
Ganciclovir—Nausea—Vincristine—colon cancer	0.000225	0.000689	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000225	0.000689	CcSEcCtD
Ganciclovir—Vomiting—Fluorouracil—colon cancer	0.000225	0.000688	CcSEcCtD
Ganciclovir—Insomnia—Capecitabine—colon cancer	0.000224	0.000683	CcSEcCtD
Ganciclovir—Rash—Fluorouracil—colon cancer	0.000223	0.000682	CcSEcCtD
Ganciclovir—Dermatitis—Fluorouracil—colon cancer	0.000223	0.000681	CcSEcCtD
Ganciclovir—Paraesthesia—Capecitabine—colon cancer	0.000222	0.000679	CcSEcCtD
Ganciclovir—Headache—Fluorouracil—colon cancer	0.000222	0.000677	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—colon cancer	0.000221	0.000675	CcSEcCtD
Ganciclovir—Dyspnoea—Capecitabine—colon cancer	0.000221	0.000674	CcSEcCtD
Ganciclovir—Nausea—Irinotecan—colon cancer	0.00022	0.000671	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—colon cancer	0.000218	0.000667	CcSEcCtD
Ganciclovir—Dyspepsia—Capecitabine—colon cancer	0.000218	0.000665	CcSEcCtD
Ganciclovir—Decreased appetite—Capecitabine—colon cancer	0.000215	0.000657	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000214	0.000652	CcSEcCtD
Ganciclovir—Fatigue—Capecitabine—colon cancer	0.000213	0.000652	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—colon cancer	0.000213	0.00065	CcSEcCtD
Ganciclovir—Pain—Capecitabine—colon cancer	0.000212	0.000646	CcSEcCtD
Ganciclovir—Constipation—Capecitabine—colon cancer	0.000212	0.000646	CcSEcCtD
Ganciclovir—Nausea—Fluorouracil—colon cancer	0.00021	0.000642	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—colon cancer	0.000209	0.00064	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—colon cancer	0.000209	0.000637	CcSEcCtD
Ganciclovir—Feeling abnormal—Capecitabine—colon cancer	0.000204	0.000623	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—colon cancer	0.000204	0.000622	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—colon cancer	0.000203	0.000619	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Capecitabine—colon cancer	0.000202	0.000618	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—colon cancer	0.000202	0.000617	CcSEcCtD
Ganciclovir—Cough—Methotrexate—colon cancer	0.000197	0.000601	CcSEcCtD
Ganciclovir—Urticaria—Capecitabine—colon cancer	0.000197	0.0006	CcSEcCtD
Ganciclovir—Body temperature increased—Capecitabine—colon cancer	0.000196	0.000597	CcSEcCtD
Ganciclovir—Abdominal pain—Capecitabine—colon cancer	0.000196	0.000597	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—colon cancer	0.000196	0.000597	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—colon cancer	0.000192	0.000587	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—colon cancer	0.000192	0.000587	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—colon cancer	0.000192	0.000587	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000191	0.000583	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—colon cancer	0.00019	0.00058	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—colon cancer	0.000186	0.000567	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—colon cancer	0.000184	0.000563	CcSEcCtD
Ganciclovir—Infection—Methotrexate—colon cancer	0.000183	0.000559	CcSEcCtD
Ganciclovir—Hypersensitivity—Capecitabine—colon cancer	0.000182	0.000557	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—colon cancer	0.00018	0.000551	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—colon cancer	0.000179	0.000546	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—colon cancer	0.000178	0.000544	CcSEcCtD
Ganciclovir—Asthenia—Capecitabine—colon cancer	0.000178	0.000542	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—colon cancer	0.000176	0.000536	CcSEcCtD
Ganciclovir—Pruritus—Capecitabine—colon cancer	0.000175	0.000535	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—colon cancer	0.000172	0.000526	CcSEcCtD
Ganciclovir—Diarrhoea—Capecitabine—colon cancer	0.000169	0.000517	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000168	0.000513	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—colon cancer	0.000167	0.000509	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—colon cancer	0.000165	0.000505	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—colon cancer	0.000164	0.000502	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—colon cancer	0.000164	0.0005	CcSEcCtD
Ganciclovir—Dizziness—Capecitabine—colon cancer	0.000164	0.0005	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—colon cancer	0.000162	0.000495	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—colon cancer	0.00016	0.000489	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—colon cancer	0.000159	0.000486	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—colon cancer	0.000159	0.000485	CcSEcCtD
Ganciclovir—Pain—Methotrexate—colon cancer	0.000158	0.000481	CcSEcCtD
Ganciclovir—Vomiting—Capecitabine—colon cancer	0.000157	0.00048	CcSEcCtD
Ganciclovir—Rash—Capecitabine—colon cancer	0.000156	0.000476	CcSEcCtD
Ganciclovir—Dermatitis—Capecitabine—colon cancer	0.000156	0.000476	CcSEcCtD
Ganciclovir—Headache—Capecitabine—colon cancer	0.000155	0.000473	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—colon cancer	0.000152	0.000464	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—colon cancer	0.000151	0.00046	CcSEcCtD
Ganciclovir—Nausea—Capecitabine—colon cancer	0.000147	0.000449	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—colon cancer	0.000146	0.000447	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—colon cancer	0.000146	0.000445	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—colon cancer	0.000146	0.000445	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—colon cancer	0.000136	0.000414	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—colon cancer	0.000132	0.000404	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—colon cancer	0.00013	0.000398	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—colon cancer	0.000126	0.000385	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—colon cancer	0.000122	0.000372	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—colon cancer	0.000117	0.000358	CcSEcCtD
Ganciclovir—Rash—Methotrexate—colon cancer	0.000116	0.000355	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—colon cancer	0.000116	0.000354	CcSEcCtD
Ganciclovir—Headache—Methotrexate—colon cancer	0.000115	0.000352	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—colon cancer	0.000109	0.000334	CcSEcCtD
